| Central Nervous System Hematopoietic and Lymphoid Cell Neoplasm studied in …STUDIED_INderived200 of 224show all (up to 200) |
|---|
| → studied in | NCT07839247Phase 2 · recruiting Zanubrutinib Plus Lenalidomide for Frail Elderly Patients With Newly Diagnosed PCNSL · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07842835not yet recruiting Registry of an Integrated Longitudinal Multimodal Biospecimen Biobank for Primary CNS Lymphoma in China (CLIMB) · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06175000Phase 2 · recruiting Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04688151Phase 1 · completed Rituximab, Acalabrutinib, and Durvalumab (RAD) in Primary CNS Lymphoma. · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04462328Phase 1 · active not recruiting Acalabrutinib and Durvalumab in Primary and Secondary Central Nervous System Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03964090Phase 2 · active not recruiting Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib, and Rituximab (TEDDI-R) in Aggressive B-cell Lymphomas With Secondary Involvement of the Central Nervous System (CNS) · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04609046Phase 1 · active not recruiting Testing the Addition of Lenalidomide and Nivolumab to the Usual Treatment for Primary CNS Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02203526Phase 1 · active not recruiting Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04464200Phase 1 · active not recruiting 19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03959085Phase 3 · recruiting Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07608731Phase 1 · not yet recruiting Golcadomide With Pemetrexed, Rituximab, and Dexamethasone for Relapsed and Refractory CNS Lymphomas · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05036577Phase 1 · completed A Dose-escalating Pilot Study of Orelabrutinib for Newly-diagnosed PCNSL · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07185373Phase 2/Phase 3 · recruiting Orelabrutinib Combined With Teniposide, Rituximab and Methotrexate for Newly Diagnosed PCNSL · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07764601NA · not yet recruiting R-MA-PD-1 Versus R-MA in Treatment-naive Primary CNS Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03962127active not recruiting MIDNOR-STROKE- a Long Term Follow-up Study of Patients With First Ever Ischemic Stroke in Central Norway · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04443829Phase 1 · active not recruiting Immunotherapy Using CAR T-cells to Target CD19 for Relapsed/Refractory CD19+ Primary CNS Lymphoma · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06607549Phase 1 · recruiting Loncastuximab Tesirine and Rituximab Following Stereotactic Radiosurgery in Patients With Central Nervous System Lymphomas (SOLAR) · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07749365Phase 2 · recruiting Hypofractionated Radiotherapy Plus GM-CSF, Pomalidomide and Glofitamab for Newly Diagnosed PCNS-DLBCL · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04906096Phase 2 · recruiting Paxalisib (GDC-0084) In Recurrent Or Refractory PCNSL · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06116110recruiting Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06940791Phase 2 · recruiting Tirabrutinib Maintenance Versus Placebo in Patients With Primary CNS Lymphoma in Complete Remission (JCOG2104) · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07710131NA · not yet recruiting Neurocognitive Assessment CNSL and LGG · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04656431Phase 1 · recruiting Feasibility of Acquiring Hyperpolarized Imaging in Patients With Primary CNS Lymphoma · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05351593Phase 1/Phase 2 · recruiting Tafasitamab Plus Lenalidomide in Relapsed CNS Lymphoma · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07082868Phase 1 · recruiting A Study of Epcoritamab and Ibrutinib in People With Central Nervous System Lymphoma (CNSL) · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04792489Phase 2 · recruiting DALY II USA/ MB-CART2019.1 for DLBCL · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05098613Phase 1 · recruiting Preliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL Patients · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06922604Phase 1 · suspended Glofitamab With Obinutuzumab Pre-treatment for the Treatment of Central Nervous System Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05131022Phase 1 · recruiting A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07198087Phase 1 · completed A Study to Investigate the Pharmacokinetics of Tirabrutinib in Participants With Mild, Moderate, and Severe Hepatic Impairment Compared to Healthy Participants · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03277729Phase 1/Phase 2 · active not recruiting A Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy Using Autologous T Cells Engineered to Express a CD20-Specific Chimeric Antigen Receptor for Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas · condition mapped CURATED_BROADER · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04906902Phase 1/Phase 2 · active not recruiting Acalabrutinib in CNSL · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06931652Phase 2 · recruiting Study of Epcoritamab in R/R Primary Diffuse Large B-cell Lymphoma of the CNS Treated With Lenalidomide and Rituximab · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04548648Phase 2 · active not recruiting A Pilot Study of Acalabrutinib in Relapsed/Refractory Primary and Secondary CNS Lymphomas · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06132737Phase 1/Phase 2 · recruiting [90Y]Y-PTT Endoradiotherapy in CNS Lymphoma Patients · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07137494Phase 1 · recruiting A Study of MB-CART19.1 Cellular Therapy for People With Central Nervous System Lymphoma (CNSL) · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Secondary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05651178early Phase 1 · active not recruiting Human CD19-CD22 Targeted T Cells Injection for Refractory/Relapsed Central Nervous System Leukemia/Lymphoma Patients · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05625594Phase 1 · recruiting Intracerebroventricular Administration of CD19-CAR T Cells (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/Mem T-lymphocytes) for the Treatment of Central Nervous System Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02883049Phase 3 · completed Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07350850Phase 2 · recruiting A Multicenter, Prospective Clinical Trial With a Concurrent Control Evaluating Methotrexate Combined With Rituximab,Sintilimab and Pirtobrutinib vs. Investigator-Selected Standard of Care in Treatment-Naive PCNSL · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05011045recruiting Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06714370completed Real-World Evidence of Effectiveness and Safety of Tirabrutinib in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma in Taiwan: A Nationwide Study · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06730542Phase 1 · recruiting Zanubrutinib in Combination With Pola-R-CHP and High-dose Methotrexate in Patients With Secondary CNS Lymphoma · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03038672Phase 2 · active not recruiting Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04627753Phase 2 · recruiting Study of Lenalidomide/Rituximab Maintenance for Transplantation Ineligible Patients With PCNSL. · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03328078Phase 1/Phase 2 · recruiting CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL) · condition mapped CURATED_BROADER · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03684980early Phase 1 · active not recruiting LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07523737Phase 2 · recruiting Pomalidomide, Anti-PD-1 Antibody Combined With Selinexor (PPS) in Relapsed/Refractory Primary Central Nervous System Diffuse Large B-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05735717Phase 2 · recruiting MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Central Nervous System Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04947319Phase 2 · active not recruiting Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study) · condition mapped CURATED_BROADER · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04830137Phase 1 · recruiting A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01011920Phase 2 · completed Trial for Patients With Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02952508Phase 2 · active not recruiting Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in Waldenstrom · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04931368Phase 3 · active not recruiting OptiMATe: De-escalated Induction Treatment in Primary CNS Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05256641Phase 1/Phase 2 · recruiting Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Secondary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05681195Phase 2 · recruiting Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04186520Phase 1/Phase 2 · recruiting CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04421560Phase 1/Phase 2 · recruiting Pembrolizumab, Ibrutinib and Rituximab in PCNSL · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06475235Phase 1 · recruiting Pembrolizumab + Chemotherapy in Newly Diagnosed PCNSL · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07416890Phase 2 · recruiting Thiotepa in Combination With Pirtobrutinib (a BTK Inhibitor) and Sintilimab (a PD-1 Inhibitor) for Frail or Relapsed/Refractory Primary or Secondary Central Nervous System Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07410520Phase 2 · recruiting PD-1 Inhibitor Combined With Rituximab, Methotrexate, and Orelabrutinib (PD-1i+RMO) for Newly Diagnosed PCNSL and SCNSL. · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07405255Phase 2 · not yet recruiting Zillion: Zanubrutinib Combined With Chemotherapy for Newly Diagnosed CNS Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07406230NA · not yet recruiting Methotrexate Early Toxicity Monitoring · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07402876Phase 3 · recruiting A Clinical Trial Evaluating Patients With Primary Vitreoretinal Lymphoma · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Primary Vitreoretinal Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03581942Phase 1/Phase 2 · completed Copanlisib With Ibrutinib for Patients With Recurrent/ Refractory Primary Central Nervous System Lymphoma (PCNSL) · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02315326Phase 1/Phase 2 · completed Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Patients With Newly Diagnosed or Refractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL) and Refractory/Recurrent Secondary Central Nervous System Lymphoma (SCNSL) · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03703167Phase 1 · completed Ibrutinib With Rituximab and Lenalidomide for Patients With Recurrent/Refractory Primary or Secondary Central Nervous System Lymphoma (PCNSL/SCNSL) · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01199562active not recruiting Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Meningeal Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04401774Phase 2 · completed Nivolumab Maintenance in Newly Diagnosed PCNSL With Persistent CSF Circulating Tumor DNA After Completion of First-Line Chemotherapy · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04134117Phase 1 · completed Tisagenlecleucel In Primary CNS Lymphoma · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05211336Phase 1 · active not recruiting Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (VIPOR) for Diffuse Large B-cell Lymphoma Involving the Central Nervous System · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06031194completed Pharmacogenomics Effects on High-Dose Methotrexate Clearance in Patients With Diffuse Large B-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06322342Phase 2 · completed Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07062627Phase 2 · recruiting Anbalcabtagene Autoleucel in Relapsed/Refractory CNS Lymphoma · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07188077recruiting Metabolic and Immunomic Differential Analysis of Primary Central Nervous System Diffuse Large B-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03375619recruiting Long-term Follow-up Study of Patients Receiving CAR-T Cells · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06712810Phase 1 · recruiting Q702 for the Treatment of Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07198464NA · not yet recruiting Relmacabtagene Autoleucel Combined With Autologous Hematopoietic Stem Cell Transplantation, Orelabrutinib, and Sintilimab for Primary Central Nervous System Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05485753Phase 1/Phase 2 · active not recruiting A Study of GNC-038, a Tetra-specific Antibody, in Patients With Central Nervous System Lymphoma (PCNSL) and Relapsed or Refractory Secondary Central Nervous System Lymphoma (SCNSL) · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05698147Phase 1/Phase 2 · recruiting Selinexor in Combination With MTX+Ritu to Treat R/R CNSL · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06115824completed New-diagnosed PCNSL Treated With Methotrexate (MTX) and Orelabrutinib-based Regimen · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05222269Phase 2 · terminated [68Ga]Ga-PentixaFor PET Imaging in CNS Lymphoma Patients · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05390814Phase 1 · completed [18F]-Fludarabine PET/MRI in Primary Central Nervous System Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06343311Phase 1/Phase 2 · recruiting T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL) · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06213636Phase 1/Phase 2 · recruiting Fourth-gen CAR T Cells Targeting CD19/CD22 for Highly Resistant B-cell Lymphoma/Leukemia (PMBCL/CNS-BCL). · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04961515Phase 2 · recruiting Orelabrutinib, Sintilimab and Temozolomide in Relapsed or Refractory Central Nervous System Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07074470NA · recruiting Combination Regimen of Teniposide, PD-1 Monoclonal Antibody and Selinixor for Patients With Relapsed or Refractory PCNSL · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05828628recruiting CLIMB: CNS Lymphoma Imaging and Molecular Biomarkers Study · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06263361recruiting Improving Safety and Accuracy of Stereotactic Brain Biopsies in Primary Central Nervous System Lymphoma. · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Cerebral Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07014943Phase 2 · recruiting High-Dose Gemcitabine, Busulfan, and Thiotepa Followed by ASCT in Primary Central Nervous System Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06541665Phase 1 · active not recruiting Phase I Study Evaluating Tolerability, Safety, Pharmacokinetics, and Efficacy of Combined ONO-4059 and R-MPV Therapy for PCNSL · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05036564NA · recruiting Diagnosis; Objective RespOnse; THErApy · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06946407NA · recruiting Rituximab, Methotrexate, and Tepadina Induction Followed by Etoposide and Cytarabine Consolidation in Primary Central Nervous System Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04737889Phase 2 · recruiting Rituximab, Lenalidomide Combined With Methotrexate and Temozolomide For Primary Central Nervous System Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05209620Phase 2 · recruiting Orelabrutinib Combined With Pemetrexed For Relapsed/Refractory Central Nervous System Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06914700completed A Nomogram for Predicting the Diagnosis of Central Malignant Tumors Based on Preoperative Clinical Characteristics and Laboratory Indicators: · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06901999Phase 2 · not yet recruiting Methotrexate or Thiotepa Combined With R-CHOP and Orelabrutinib in CNSL Patients · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06876688Phase 2 · recruiting Relma-cel Followed by Tislelizumab for the Treatment of Relapsed/Refractory CNS Large B-Cell Lymphoma · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03770416Phase 2 · completed Nivolumab and Ibrutinib in Treating Patients With Relapsed or Refractory Central Nervous System Lymphoma · condition mapped CURATED_BROADER · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06832267NA · recruiting Rituximab-Methotrexate-Temozolomide-Thiotepa (RMTT) Regimen As First-line Therapy for PCNS DLBCL · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06830421Phase 3 · recruiting Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochemotherapy in Elderly PCNSL Patients · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03495960Phase 2 · completed Study on Tailored Treatment in Elderly Patients With Newly Diagnosed Primary Lymphoma of Central Nervous System · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04841434Phase 1/Phase 2 · completed A Phase I/II Study to Investigate the Use of VORAXAZE™ As Intended Intervention in Patients with CNSL · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06737250Phase 2 · recruiting NB02 (Poseltinib) Combined Rituximab and Lenalidomide in R/R PCNSL · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04521946Phase 1 · withdrawn Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Intracranial Myeloid Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06646211Phase 2 · not yet recruiting High-dose Methotrexate Combined with Thiotepa and Zanubrutinib in the Treatment of Newly Diagnosed PCNSL (MTZ) · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04070040Phase 2 · recruiting Camrelizumab for Patients with Recurrent Primary Central Nervous System Lymphoma (PCNSL) · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06625359Phase 2 · terminated High-dose Chemotherapy with Thiotepa, Busulfan, and Cyclophosphamide Followed by Autologous Stem Cell Transplantation in Central Nervous System Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06554561Phase 1/Phase 2 · recruiting A Study of Pomadomide in Combination With Rituximab and Methotrexate for Newly-diagnosed Primary Central Nervous System Lymphoma · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06454266Phase 2 · completed First-line Treatment of PCNSL With the Combination of Orelabrutinib, Rituximab, and Methotrexate (ORM Regimen) · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06445257NA · unknown A Clinical Study Evaluating the Safety and Efficacy of ZRMT Regimen in the Treatment of PCNSL · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01588015Phase 1 · completed Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00596154Phase 2 · completed Rituximab, Methotrexate, Procarbazine and Vincristine Followed by High-dose Chemotherapy With Autologous Stem-cell Rescue in Newly-diagnosed Primary CNS Lymphoma · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01421524Phase 1 · completed Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03255018Phase 2 · completed Pembrolizumab in Relapsed and Refractory Gray-Zone Lymphoma (GZL), Primary Central Nervous System Lymphoma (PCNSL), and Other Extranodal Diffuse Large B-cell Lymphomas · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05114330unknown Secondary Central Nervous System Lymphoma Registry - Charité · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01000753completed Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05896007Phase 2 · unknown Zanubrutinib Combined With Rituximab and Chemotherapy for Newly-Diagnosed PCNSLBCL Patients Intolerant to HSCT · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05926427Phase 2 · unknown Orelabrutinib Combined With Rituximab and Chemotherapy for Relapsed/Refractory B-Cell Lymphoma Patients With Central Nervous System Involvement · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05950490unknown Construction of Diagnosis and Treatment System for Primary Vitreoretinal Lymphoma · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Primary Vitreoretinal Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05242146Phase 1 · terminated GB5121 in Adult Patients With Relapsed/Refractory CNS Lymphoma · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05816746Phase 2 · unknown Decitabine and Anti-PD-1 in R/R DLBCL · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02655744unknown Prospective Neurobehavioral Outcomes Follow-up in Primary CNS Lymphoma Patients Treated With Cranial Radiotherapy Combined With or Without MTX-based Chemotherapy According to the Multidisciplinary Treatment Guidelines Implemented at a Single Institute · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04006561recruiting Prospective Neurobehavioral Functions in Newly-diagnosed Patients With Primary CNS Lymphoma Treated With Hyperfractionated Conformal Whole-brain Radiation Therapy Plus Simultaneous Integrated Boost · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01182415Phase 2 · completed High Dose Chemotherapy and Stem Cell Transplant for Non-Hodgkin's Lymphoma or Central Nervous System (CNS) Lymphoma · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05667402NA · unknown Clinical Study of TBF Regimen in Allo-HSCT in Patients With CNS Leukemia · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04934579Phase 2 · completed Rituximab,Methotrexate and Lenalidomide in Newly Diagnosed Primary Central Nervous System Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01647971Phase 1/Phase 2 · completed Study of the Efficacy and Safety of Ublituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04481815Phase 2 · unknown Rituximab Plus Methotrexate With or Without Lenalidomide in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05600660Phase 2 · recruiting Orelabrutinib,Rituximab and Methotrexate in Newly Diagnosed Primary Central Nervous System Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05135858Phase 1 · unknown Dose Dense Re-challenge of High Dose Methotrexate With Glucarpidase for Relapsed Primary Central Nervous System Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04438044Phase 2 · unknown A Study to Evaluate ICP-022 in Patients With R/R PCNSL and SCNSL · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05549284Phase 2 · unknown Orelabrutinib,Rituximab and Methotrexate in Newly-diagnosed Primary Central Nervous System Lymphoma(PCNSL) · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05518383Phase 4 · recruiting B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021 · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03342586completed Using a Novel Functional MRI Technique to Evaluate for Neurotoxicity · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01458730Phase 2 · completed Nordic Study in Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05117814NA · unknown Zanubrutinib Monotherapy in Relapsed/Refractory Central Nervous System Lymphoma · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04845139NA · unknown A Case Study of Nivolumab for Relapsed/Refractory Primary Central Nervous System Lymphoma · condition mapped CURATED_BROADER · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05425654Phase 2 · unknown RL-MPV Followed by BBC HCT Using Autologous Stem Cells and Maintenance Therapy With Nivolumab for Newly Diagnosed PCNSL · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00103038NA · completed Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04831658Phase 1/Phase 2 · unknown A Prospective Clinical Study of BTK Inhibitor, PD-1 and Formustine in the First-line Treatment of Primary Central Nervous System Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05398224Phase 2 · unknown R-MTX-zanbrutinib in Secondary CNS Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Secondary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05390749Phase 2 · unknown Sequential Treatment With RO-MTX After Pomalidomide, Orelabrutinib, Rituximab (POR) in Newly-diagnosed PCNSL · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02623010Phase 2 · unknown Bruton's Tyrosine Kinase Inhibitor Ibrutinib as Maintenance Treatment in Elderly Patients With Primary CNS Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05347641Phase 2 · not yet recruiting Penpulimab Combined With RMA Treatment of Primary Diagnosis of Primary Central Nervous System Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05334238Phase 3 · unknown Orelabrutinib Maintenance Therapy After ASCT in Primary Central Nervous System Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04514393Phase 2 · unknown Ibrutinib With Methotrexate and Temozolomide for Patients With Newly Diagnosed Primary CNS Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02420795Phase 1/Phase 2 · terminated Akt/ERK Inhibitor ONC201 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05293990NA · completed Usefulness of Gadovist-enhanced FLAIR Imaging · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Cerebral Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05274139Phase 2 · completed Treatment of Primary CNS Lymphoma ( FTD ) · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02313389Phase 3 · unknown Maintenance Treatment Versus Observation in Elderly Patients With PCNS Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05260619Phase 2 · recruiting Lenalidomide Maintenance Treatment in Patients With Primary Central Nervous System Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04253496unknown Mathematic Modeling at Micro and Macroscopic Level of Primary Central Nervous System Lymphomas (PCNSL) · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04073147Phase 1 · terminated Venetoclax and Obinutuzumab for Relapsed/Refractory Primary CNS Lymphoma · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05167630unknown Prognosis Factors in Patients With Primary Central Nervous System Lymphoma · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05054426Phase 3 · unknown Intermediate Dose of IV MTX as CNS Prophylaxis for High Risk DLBCL · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00293475Phase 1/Phase 2 · unknown Methotrexate, Mannitol, Rituximab, and Carboplatin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03582254NA · unknown Role of [18F]-FDG Brain PET in Newly Diagnosed Primary Cerebral Lymphoma, in Immunocompetent Patient Older Than 60 Years · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05021770Phase 1/Phase 2 · unknown Orelabrutinib in Combination With Thiotepa in Refractory and Relapsed Primary CNS Lymphoma · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04129710Phase 2 · unknown A Trial to Compare Ibrutinib Versus Lenalidomide in Combination With MRE-chemotherapy for Adult Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04938297Phase 2 · unknown Rituximab,Zanubrutinib in Combination With Lenalidomide, Followed by Zanubrutinib or Lenalidomide Maintenance in Patients With Primary or Secondary CNS Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04899427Phase 2 · unknown Phase II Study of Orelabrutinib Combined With PD-1 Inhibitor in Relapsed/Refractory Primary Central Nervous System Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04899453Phase 2 · unknown Intravitreal MTX and ZR Regimen in Newly Diagnosed PVRL · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Primary Vitreoretinal Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00489203Phase 2 · completed Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Meningeal Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03569995Phase 2 · unknown [CREMA]Combination of R-M Followed by R-A in Elderly Patients With Primary CNS Lymphoma · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04457869Phase 2 · unknown A Study of F520 in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) or Secondary Central Nervous System Lymphoma (SCNSL) · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02657785Phase 2/Phase 3 · recruiting Treatment of PCNSL With R-IDARAM and Intrathecal Immunochemotherapy · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02836158Phase 2/Phase 3 · recruiting Therapeutic Effects of R-IDARAM and Intrathecal Immunochemotherapy on Elderly Patients With PCNSL · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04516655Phase 2 · unknown A Phase II Trail of Chidamide ,Rituximab and Methotrexate in Lymphoma Patients · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01973062Phase 2 · terminated Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Primary Central Nervous System Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04120350Phase 1/Phase 2 · unknown R2-MTX With Lenalidomide Maintenance in Newly-diagnosed PCNSL：a Multicenter Phase Ib/II Stuty · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00267865Phase 2 · completed Chemotherapy and HAART to Treat AIDS-related Primary Brain Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | AIDS-Related Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00918333Phase 1/Phase 2 · completed Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01251913terminated A Pilot Study of Inpatient Hospice With Procurement of Brain Tumor Tissue on Expiration for Research Purposes · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02652715NA · completed Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04083066Phase 4 · unknown Open Randomized Prospective Clinical Study of R-FPD Versus R-MAD Regimen in the Treatment of Primary Central Nervous System Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04066920Phase 2 · unknown IBER Salvage Treatment Followed by Ibrutinib Maintenance for Relapsed or Refractory PCNSL · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01722305Phase 1 · completed Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma or Newly Diagnosed or Relapsed or Refractory Intraocular Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02669511Phase 2 · completed PQR309 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03558750Phase 1 · terminated Rituximab, Lenalidomide, and Nivolumab in Treating Participants With Relapsed or Refractory Non-Germinal Center Type Diffuse Large B Cell Lymphoma or Primary Central Nervous System Lymphoma · condition mapped CURATED_BROADER · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03859544unknown Molecular Prognosis of Lymphomas of the Central Nervous System (ALYCE-molecular) · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00863460Phase 2 · unknown Cranial Radiotherapy or Intensive Chemotherapy With Hematopoietic Stem Cell Rescue for Primary Central Nervous System Lymphoma in Young Patients · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01319591completed Comparison of Creatinine Clearance Calculation for Estimation of GFR in Patients Receiving HD Methotrexate · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03120000Phase 2 · withdrawn PQR309 in Phase 2 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03733327Phase 2/Phase 3 · unknown BUCYE Conditioning Regimen for PCNSL Undergoing Auto-HSCT · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03690895completed Long-term Outcome of AIDS-related Primary Central Nervous System Lymphoma Treated With High Dose Methotrexate and Combined Antiretroviral Therapy · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03212807Phase 2 · withdrawn Study Of Durvalumab and Lenalidomide In R/R EBV Associated DLBCL Subtypes, Primary CNS And Testicular DLBCL · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01789255Phase 2 · completed Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01053494NA · completed Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Meningeal Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03392714Phase 2 · unknown Bendamustine-based Combination Therapy for PCNSL · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02301364Phase 2 · completed Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL) · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112593NA · completed Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | AIDS-Related Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00710151terminated Neurotoxicity in Primary Central Nervous System Lymphoma (PCNSL): An International Observational Study of Cognition in Long Term Survivors · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01944943Phase 2 · terminated Phase II Study of Vismodegib in Patients With Refractory or Relapsed B-cell Lymphoma or Chronic Lymphocytic Leukemia · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00193973Phase 2 · completed Idarubicin Based Combined Modality Therapy in Primary CNS Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02113007Phase 2 · terminated Study of High-Dose Rituximab With Temozolomide as Treatment for Primary Central Nervous System (CNS) Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02983942Phase 1/Phase 2 · unknown Ketogenic Diet Adjunctive to HD-MTX Chemotherapy for Primary Central Nervous System Lymphoma · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02934204Phase 2 · unknown Temozolomide in Treatment of Patients With Primary Central Nervous System Lymphoma · condition mapped ALIAS · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02779101Phase 2 · unknown Study on Pembrolizumab for Recurrent Primary Central Nervous System Lymphoma (PCNSL) · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00967200completed Study of Tissue Samples From Patients With Glioma or Other Brain Tumors · condition mapped ONTOLOGY_EXACT · 224 trials mapped (93 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |